Efficacy and Safety of Ribociclib in Combination With NSAI Versus Physician ' s Choice of Chemotherapy Sequential Endocrine Therapy in HR+/HER2- Advanced Breast Cancer

Conditions: Advanced Breast Cancer Interventions: Drug: physician ' s choice of chemotherapy sequential Ribociclib combined with NSAI ±OFS; Drug: Ribociclib combined with NSAI±OFS Sponsors: The First Affiliated Hospital with Nanjing Medical University; Zhejiang Cancer Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials